4-[[1-[(2~{S},3~{S},5~{R})-2-(hydroxymethyl)-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]oxolan-3-yl]-1,2,3-triazol-4-yl]methoxy]benzenesulfonamide

InChIKey	`PKERXAQSXFSAIU-GVDBMIGSSA-N`
Compound Name	4-[[1-[(2~{S},3~{S},5~{R})-2-(hydroxymethyl)-5-[5-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]oxolan-3-yl]-1,2,3-triazol-4-yl]methoxy]benzenesulfonamide
Canonical SMILES	`Cc1cn([C@H]2C[C@H](n3cc(COc4ccc(S(N)(=O)=O)cc4)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	6
Pfam Stratification	Homologous
Avg pChEMBL	7.45
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q16790	CA9	Homo sapiens	Human	PF00194	8.2	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	8.0	Ki	ChEMBL;BindingDB
P43166	CA7	Homo sapiens	Human	PF00194	7.3	Ki	ChEMBL;BindingDB
P35218	CA5A	Homo sapiens	Human	PF00194	7.2	Ki	ChEMBL;BindingDB
O43570	CA12	Homo sapiens	Human	PF00194	7.1	Ki	ChEMBL;BindingDB
Q9Y2D0	CA5B	Homo sapiens	Human	PF00194	6.8	Ki	ChEMBL;BindingDB